The present invention relates to compounds of formula I
wherein R
1
and R
2
are described hereinbelow. These compounds have high affinity to A
2A
receptors and good selectivity to A
1
and A
3
receptors. These compounds are useful, inter alia, in the treatment of Alzheimer's disease, depression, Parkinson's disease and ADHD.